Facial Paralysis Clinical Trial
Official title:
A Phase 2a, Multicenter, Randomized, Subject and Evaluator Blinded, Controlled Study Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.
This study involves the use of an Investigational Product called NTX-001. It is a product used in the repair of nerve injuries. It is used in the operating room. The main purposes of this study are to 1) see how safe NTX-001 is when used in nerve repair and, 2) see if your nerve becomes functional in a shorter period of time when compared to what is normally done to treat nerve injuries.
Facial paralysis can be a consequence of traumatic facial nerve injury, iatrogenic causes, malignancy, congenital syndromes, and viral infections. Prolonged paralysis can result in ocular complications, articulation difficulties, impaired feeding, and difficulty in conveying emotion through expressive movement. The current treatment for permanent facial paralysis is facial reanimation surgery, which encompasses a broad range of procedures that restore form and function to the paralyzed face. The importance of understanding the health utility of facial paralysis and the value of facial reanimation surgery increases. PEG-fusion is a promising therapy for patients that have or will have nerve conditions or injuries resulting in facial palsy that can be addressed surgically. Patients that have clinical evidence of facial paralysis requiring facial nerve repair from conditions or interventions that have or may result in paralysis will be evaluated for participation. The primary objective is to assess the safety of NTX-001 across 12 months following the nerve repair. The study will measure improvement in Facial Grading System (FG) for efficacy. Additionally, measures will include an EMG evaluation for assessment of nerve function intraoperatively, image-based automatic facial landmark analysis, improvement in Facial Clinimetric Evaluation Scale score, and Patient Global Impression of Change Response (PGIC). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01537952 -
Microbiologic Findings of Acute Facial Palsy in Children
|
N/A | |
| Recruiting |
NCT06335719 -
Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome
|
N/A | |
| Recruiting |
NCT04934176 -
3D Dynamic and Patient-Centered Outcomes of Facial Reanimation Surgery in Patients With Facial Paralysis
|
||
| Completed |
NCT03974763 -
Function and Form Outcomes in Patients With Facial Paralysis
|
||
| Active, not recruiting |
NCT05997199 -
The Effect Vitamin D on the Recovery Rate of Bell Palsy
|
||
| Withdrawn |
NCT03622697 -
Effects of Mindfulness Meditation on Facial Paralysis Patients
|
N/A | |
| Completed |
NCT02988856 -
Magnetic Correction of Eye Lid Paralysis
|
N/A | |
| Completed |
NCT00989209 -
Myofunctional Therapy in Facial Palsy
|
N/A | |
| Enrolling by invitation |
NCT05945615 -
Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis
|
Phase 3 | |
| Completed |
NCT05585333 -
Photobiomodulation Therapy Treatment on Facial Paralysis
|
N/A | |
| Enrolling by invitation |
NCT04215562 -
Outcome of Facial Palsy Following Rehabilitation
|
N/A | |
| Recruiting |
NCT05191719 -
Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy
|
N/A | |
| Recruiting |
NCT03115203 -
Morphometric Study of the Muscles of the Skin in MRI 3 Tesla in Patients With Facial Paralysis.
|
N/A | |
| Completed |
NCT02527226 -
Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors
|
N/A | |
| Completed |
NCT04153916 -
Artificial Eye Blinking Stimulation Following Paralysis of the Facial Nerve
|
N/A | |
| Not yet recruiting |
NCT05222698 -
Free Neurovascularized Muscle Transfer in Facial Reanimation of Long-standing Facial Palsy Patients
|
N/A |